ILLUMINA INC.
Company Snapshot
Company Overview
Illumina Inc. develops, manufactures, and markets DNA sequencing systems, microarray platforms, reagents, and analysis software for studying genetic variation and function. It offers comprehensive sequencing and array solutions for academic, clinical, and translational uses in more than 150 countries. In cancer profiling, it is positioned within the next-generation sequencing segment, with activities spanning research-use and clinical testing workflows. Its technology framework supports comprehensive genomic profiling of solid tumors through DNA- and RNA-based assays, integrated informatics, and bioinformatics pipelines designed for large-scale molecular analysis.
Illumina maintains manufacturing, R&D, and commercial facilities across North America, Europe, and Asia-Pacific through direct sales and distributor networks.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
ILLUMINA INC. In News
Company's Business Segments
- Core Illumina : It includes consumables, instruments, services and other revenue.
Applications/End User Industries
- Next-Generation Sequencing (NGS)
- Cutting-Edge Array Scanners
- In Vitro Diagnostic (IVD)
- Reagents
- Microarray Kits
- Genotyping
- Epigenetic Analysis
- Vitro Diagnostic
- Oncology Comprehensive
- Sequencing Platform Comparison
- Designstudio Software
- Trusight Oncology
- Basespace Sequence Hub
- Dragen Secondary Analysis
- Illumina Connected Analytics
- Genomic Insights
- Oncology Clinical Research
- Laboratory Information Management System
- Correlation Engine
- Microarray Data Analysis
- DNA Prep Portfolio
- Life Sciences